Lecanemab and amyloid-related imaging abnormalities: Real-world data from a single center experience
{{output}}
Introduction: Lecanemab has demonstrated both safety and efficacy in clinical trials; however, routine clinical data are sparse. We contribute to the growing body of real-world safety data, with a special focus on amyloid-related... ...
